Skip to main content

Table 1 Demographic details of the COPD and control subjects

From: The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD

Subjects

Controls

COPD

No. of subjects

14

10

Age (years)

56 (± 8)

58 (± 16)

FEV1, % pred

110.4 (± 9)

60.5 (± 20)

FEV1, % FVC

96 (± 12)

58 (± 15)*

Male/Female

8/6

6/4

  1. Data shown as mean ± SEM.
  2. Abbreviations: COPD: chronic obstructive pulmonary disease. FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; *P < 0.05 compared to controls.
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us